Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation.

HealthDay News — Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs), according to a study published online January 6 in ...

Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.

Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Posdinemab works by targeting and neutralizing Alzheimer disease-specific phosphorylated tau, preventing its spread to other neurons.

HealthDay News — For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about 40% do not seroconvert, according to a research letter ...